enVVeno Medical (NVNO) EBITDA Margin (2018 - 2019)
Historic EBITDA Margin for enVVeno Medical (NVNO) over the last 2 years, with Q1 2019 value amounting to 5064.63%.
- enVVeno Medical's EBITDA Margin fell 3762800.0% to 5064.63% in Q1 2019 from the same period last year, while for Dec 2019 it was 24566.5%, marking a year-over-year decrease of 203559900.0%. This contributed to the annual value of 4231.07% for FY2020, which is 287975700.0% up from last year.
- According to the latest figures from Q1 2019, enVVeno Medical's EBITDA Margin is 5064.63%, which was down 3762800.0% from 5905.47% recorded in Q4 2018.
- enVVeno Medical's 5-year EBITDA Margin high stood at 3570.75% for Q3 2018, and its period low was 5905.47% during Q4 2018.